We are live on ! Find out more
NRC icon

NRC Health Common Stock

116 hedge funds and large institutions have $414M invested in NRC Health Common Stock in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 45 increasing their positions, 43 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

5% more funds holding

Funds holding: 110116 (+6)

5% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 43

0.13% more ownership

Funds ownership: 47.25%47.38% (+0.13%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less capital invested

Capital invested by funds: $466M → $414M (-$52.2M)

Holders
116
Holders Change
+6
Holders Change %
+5.45%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
45
Reduced
43
Closed
4
Calls
$15K
Puts
Net Calls
+$15K
Net Calls Change
+$8K
Name Holding Trade Value Shares
Change
Change in
Stake
Select Equity Group
26
Select Equity Group
New York
$1.58M -$31.3K -808 -2%
SEI Investments
27
SEI Investments
Pennsylvania
$1.57M +$638K +16,500 +64%
WJWM
28
Williams Jones Wealth Management
New York
$1.57M -$39 -1 -0%
Ameriprise
29
Ameriprise
Minnesota
$1.5M +$5.72K +148 +0.4%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$1.45M -$349K -9,016 -19%
Swiss National Bank
31
Swiss National Bank
Switzerland
$1.34M
APC
32
Alpine Peaks Capital
New York
$1.32M -$718K -18,558 -34%
WIC
33
Willis Investment Counsel
Georgia
$1.26M -$146K -3,768 -10%
Janus Henderson Group
34
Janus Henderson Group
United Kingdom
$1.17M -$1.41M -36,473 -54%
AQR Capital Management
35
AQR Capital Management
Connecticut
$1.16M +$125K +3,223 +12%
TC
36
TownSquare Capital
Utah
$1.14M +$316K +8,171 +36%
Goldman Sachs
37
Goldman Sachs
New York
$1.07M -$243K -6,279 -18%
CS
38
Credit Suisse
Switzerland
$973K +$155K +4,000 +18%
AG
39
Algert Global
California
$906K +$172K +4,440 +22%
Invesco
40
Invesco
Georgia
$879K +$47.5K +1,228 +5%
BA
41
Bridgewater Associates
Connecticut
$835K -$285K -7,359 -25%
UBS AM
42
UBS AM
Illinois
$795K +$19K +490 +2%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$691K -$1.55K -40 -0.2%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$664K +$6K +155 +0.9%
Stifel Financial
45
Stifel Financial
Missouri
$630K -$122K -3,157 -16%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$604K +$626K +16,189 New
Neuberger Berman Group
47
Neuberger Berman Group
New York
$601K -$26.5K -684 -4%
AAM
48
Azzad Asset Management
Virginia
$595K +$6.38K +165 +1%
SCP
49
Seizert Capital Partners
Michigan
$577K
AllianceBernstein
50
AllianceBernstein
Tennessee
$562K +$19.3K +500 +3%

NRC Hedge Fund Activity: Q4 2022 in Review

116 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q4 2022, worth a combined $414M — down 11% from $466M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NRC positions and 4 closed out — a net gain of 8 holders — while 45 added to existing stakes and 43 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.8M. The largest seller was Mawer Investment Management, exiting entirely with an estimated $2.39M sold.

  • 116 institutional investors held NRC Health Common Stock (NRC) as of Q4 2022, up from 110 in Q3 2022.
  • Funds reported $414M of NRC Health Common Stock stock for Q4 2022, down 11% quarter-over-quarter.
  • 12 funds opened new NRC Health Common Stock positions in Q4 2022 and 4 closed out, a net change of +8 holders.
  • The largest NRC Health Common Stock buyer in Q4 2022 was Morgan Stanley, an estimated $36.8M added.
  • The largest NRC Health Common Stock seller in Q4 2022 was Mawer Investment Management, an estimated $2.39M sold.

Based on aggregated 13F filings for Q4 2022.